1887
Surveillance Open Access
Like 0

Abstract

Background

Leptospirosis is a zoonotic disease caused by bacteria of the genus . Humans are infected by exposure to animal urine or urine-contaminated environments. Although disease incidence is lower in Europe compared with tropical regions, there have been reports of an increase in leptospirosis cases since the 2000s in some European countries.

Aim

We aimed to describe the epidemiology of reported cases of leptospirosis in the European Union/European Economic Area (EU/EEA) during 2010−2021 and to identify potential changes in epidemiological patterns.

Methods

We ran a descriptive analysis of leptospirosis cases reported by EU/EEA countries to the European Centre for Disease Prevention and Control with disease during 2010−2021. We also analysed trends at EU/EEA and national level.

Results

During 2010–2021, 23 countries reported 12,180 confirmed leptospirosis cases corresponding to a mean annual notification rate of 0.24 cases per 100,000 population. Five countries (France, Germany, the Netherlands, Portugal and Romania) accounted for 79% of all reported cases. The highest notification rate was observed in Slovenia with 0.82 cases per 100,000 population. Overall, the notification rate increased by 5.0% per year from 2010 to 2021 (95% CI: 1.2–8.8%), although trends differed across countries.

Conclusion

The notification rate of leptospirosis at EU/EEA level increased during 2010−2021 despite including the first 2 years of the COVID-19 pandemic and associated changes in population behaviours. Studies at (sub)national level would help broaden the understanding of differences at country-level and specificities in terms of exposure to , as well as biases in diagnosis and reporting.

Loading

Article metrics loading...

/content/10.2807/1560-7917.ES.2024.29.7.2300266
2024-02-15
2024-12-21
/content/10.2807/1560-7917.ES.2024.29.7.2300266
Loading
Loading full text...

Full text loading...

/deliver/fulltext/eurosurveillance/29/7/eurosurv-29-7-4.html?itemId=/content/10.2807/1560-7917.ES.2024.29.7.2300266&mimeType=html&fmt=ahah

References

  1. Haake DA, Levett PN. Leptospirosis in humans. Curr Top Microbiol Immunol. 2015;387:65-97.  https://doi.org/10.1007/978-3-662-45059-8_5  PMID: 25388133 
  2. Sykes JE, Reagan KL, Nally JE, Galloway RL, Haake DA. Role of diagnostics in epidemiology, management, surveillance, and control of leptospirosis. Pathogens. 2022;11(4):395.  https://doi.org/10.3390/pathogens11040395  PMID: 35456070 
  3. Costa F, Hagan JE, Calcagno J, Kane M, Torgerson P, Martinez-Silveira MS, et al. Global morbidity and mortality of leptospirosis: a systematic review. PLoS Negl Trop Dis. 2015;9(9):e0003898.  https://doi.org/10.1371/journal.pntd.0003898  PMID: 26379143 
  4. Torgerson PR, Hagan JE, Costa F, Calcagno J, Kane M, Martinez-Silveira MS, et al. Global burden of leptospirosis: estimated in terms of disability adjusted life years. PLoS Negl Trop Dis. 2015;9(10):e0004122.  https://doi.org/10.1371/journal.pntd.0004122  PMID: 26431366 
  5. Jansen A, Schöneberg I, Frank C, Alpers K, Schneider T, Stark K. Leptospirosis in Germany, 1962-2003. Emerg Infect Dis. 2005;11(7):1048-54.  https://doi.org/10.3201/eid1107.041172  PMID: 16022779 
  6. Baranton G, Postic D. Trends in leptospirosis epidemiology in France. Sixty-six years of passive serological surveillance from 1920 to 2003. Int J Infect Dis. 2006;10(2):162-70.  https://doi.org/10.1016/j.ijid.2005.02.010  PMID: 16298537 
  7. Goris MG, Boer KR, Duarte TA, Kliffen SJ, Hartskeerl RA. Human leptospirosis trends, the Netherlands, 1925-2008. Emerg Infect Dis. 2013;19(3):371-8.  https://doi.org/10.3201/eid1903.111260  PMID: 23622144 
  8. Bourhy PSA, Picardeau M. Diagnostic, surveillance et épidémiologie de la leptospirose en France. (Diagnosis, surveillance and epidemiology of leptospirosis in France].Bull Epidemiol Hebd (Paris). 2017; (8-9):131-7. French. Available from: http://beh.santepubliquefrance.fr/beh/2017/8-9/2017_8-9_1.html
  9. Pijnacker R, Goris MG, Te Wierik MJ, Broens EM, van der Giessen JW, de Rosa M, et al. Marked increase in leptospirosis infections in humans and dogs in the Netherlands, 2014. Euro Surveill. 2016;21(17).  https://doi.org/10.2807/1560-7917.ES.2016.21.17.30211  PMID: 27168584 
  10. Bandara M, Ananda M, Wickramage K, Berger E, Agampodi S. Globalization of leptospirosis through travel and migration. Global Health. 2014;10(1):61.  https://doi.org/10.1186/s12992-014-0061-0  PMID: 25112368 
  11. Jensenius M, Han PV, Schlagenhauf P, Schwartz E, Parola P, Castelli F, et al. Acute and potentially life-threatening tropical diseases in western travelers--a GeoSentinel multicenter study, 1996-2011. Am J Trop Med Hyg. 2013;88(2):397-404.  https://doi.org/10.4269/ajtmh.12-0551  PMID: 23324216 
  12. EUR-Lex. Commission implementing Decision (EU) 2018/945 of 22 June 2018 - on the communicable diseases and related special health issues to be covered by epidemiological surveillance as well as relevant case definitions. European Union. Available from: https://eur-lex.europa.eu/eli/dec_impl/2018/945
  13. European Centre for Disease Prevention and Control (ECDC). Leptospirosis: annual epidemiological report for 2020. Stockholm: ECDC; 2022. Available from: https://www.ecdc.europa.eu/sites/default/files/documents/Leptospirosis_AER_2020_Final.pdf
  14. European Centre for Disease Prevention and Control (ECDC). Surveillance systems overview for 2020. Stockholm: ECDC. [Accessed: 30 Jan 2024]. Available from: https://www.ecdc.europa.eu/en/publications-data/surveillance-systems-overview-2020
  15. Lionello L, Stranges D, Karki T, Wiltshire E, Proietti C, Annunziato A, et al. Non-pharmaceutical interventions in response to the COVID-19 pandemic in 30 European countries: the ECDC-JRC Response Measures Database. Euro Surveill. 2022;27(41):2101190.  https://doi.org/10.2807/1560-7917.ES.2022.27.41.2101190  PMID: 36239171 
  16. Crane MA, Popovic A, Panaparambil R, Stolbach AI, Romley JA, Ghanem KG. Reporting of infectious diseases in the united states during the coronavirus disease 2019 (COVID-19) pandemic. Clin Infect Dis. 2022;74(5):901-4.  https://doi.org/10.1093/cid/ciab529  PMID: 34097015 
  17. Gonçalves AT, Paiva C, Melo-Mota F, Vieira ML, Carreira T, Nunes MS, et al. First isolation of human Leptospira strains, Azores, Portugal. Int J Infect Dis. 2010 2010/09/01/;14:e148-e53.  https://doi.org/10.1016/j.ijid.2009.12.004  PMID: 20413339 https://doi.org/10.1016/j.ijid.2009.12.004 
  18. Bakoss P, Macháčová E, Jareková J. Long-term trends in the epidemiology of human leptospirosis (Slovak Republic, 1954-2006). Eur J Clin Microbiol Infect Dis. 2012;31(9):2167-76.  https://doi.org/10.1007/s10096-012-1551-8  PMID: 22354522 
  19. van Alphen LB, Lemcke Kunoe A, Ceper T, Kahler J, Kjelso C, Ethelberg S, et al. Trends in human leptospirosis in Denmark, 1980 to 2012. Euro Surveill. 2015;20(4):21019.  https://doi.org/10.2807/1560-7917.ES2015.20.4.21019  PMID: 25655055 
  20. Mwachui MA, Crump L, Hartskeerl R, Zinsstag J, Hattendorf J. Environmental and behavioural determinants of leptospirosis transmission: a systematic review. PLoS Negl Trop Dis. 2015;9(9):e0003843.  https://doi.org/10.1371/journal.pntd.0003843  PMID: 26379035 
  21. Walker MD. Leptospirosis: the possible risk to those participating in water-based sports and activities. Br J Gen Pract. 2018;68(673):394-5.  https://doi.org/10.3399/bjgp18X698285  PMID: 30049778 
  22. Monahan AM, Miller IS, Nally JE. Leptospirosis: risks during recreational activities. J Appl Microbiol. 2009;107(3):707-16.  https://doi.org/10.1111/j.1365-2672.2009.04220.x  PMID: 19302325 
  23. European Environment Agency. Climate change as a threat to health and well-being in Europe: focus on heat and infectious diseases. Luxembourg: Publications Office of the European Union; 2022.  https://doi.org/10.2800/67519  https://doi.org/10.2800/67519 
  24. Baharom M, Ahmad N, Hod R, Arsad FS, Tangang F. The impact of meteorological factors on communicable disease incidence and its projection: a systematic review. Int J Environ Res Public Health. 2021;18(21):11117.  https://doi.org/10.3390/ijerph182111117  PMID: 34769638 
  25. Mora C, McKenzie T, Gaw IM, Dean JM, von Hammerstein H, Knudson TA, et al. Over half of known human pathogenic diseases can be aggravated by climate change. Nat Clim Chang. 2022;12(9):869-75.  https://doi.org/10.1038/s41558-022-01426-1  PMID: 35968032 
  26. Dreesman J, Toikkanen S, Runge M, Hamschmidt L, Lüsse B, Freise JF, et al. Investigation and response to a large outbreak of leptospirosis in field workers in Lower Saxony, Germany. Zoonoses Public Health. 2023;70(4):315-26.  https://doi.org/10.1111/zph.13027  PMID: 36692076 
  27. Guillois Y, Bourhy P, Ayral F, Pivette M, Decors A, Aranda Grau JH, et al. An outbreak of leptospirosis among kayakers in Brittany, North-West France, 2016. Euro Surveill. 2018;23(48):1700848.  https://doi.org/10.2807/1560-7917.ES.2018.23.48.1700848  PMID: 30621819 
  28. Hartskeerl RA, Collares-Pereira M, Ellis WA. Emergence, control and re-emerging leptospirosis: dynamics of infection in the changing world. Clin Microbiol Infect. 2011;17(4):494-501.  https://doi.org/10.1111/j.1469-0691.2011.03474.x  PMID: 21414083 
  29. Barragan V, Olivas S, Keim P, Pearson T. Critical knowledge gaps in our understanding of environmental cycling and transmission of Leptospira spp. Appl Environ Microbiol. 2017;83(19):e01190-17.  https://doi.org/10.1128/AEM.01190-17  PMID: 28754706 
  30. Rood EJJ, Goris MGA, Pijnacker R, Bakker MI, Hartskeerl RA. Environmental risk of leptospirosis infections in the Netherlands: Spatial modelling of environmental risk factors of leptospirosis in the Netherlands. PLoS One. 2017;12(10):e0186987.  https://doi.org/10.1371/journal.pone.0186987  PMID: 29065186 
/content/10.2807/1560-7917.ES.2024.29.7.2300266
Loading

Data & Media loading...

Supplementary data

Submit comment
Close
Comment moderation successfully completed
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error